217 related articles for article (PubMed ID: 24659244)
1. A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia.
Ludwig H; Aapro M; Bokemeyer C; Glaspy J; Hedenus M; Littlewood TJ; Österborg A; Rzychon B; Mitchell D; Beguin Y
Support Care Cancer; 2014 Aug; 22(8):2197-206. PubMed ID: 24659244
[TBL] [Abstract][Full Text] [Related]
2. Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries.
Stein J; Bager P; Befrits R; Gasche C; Gudehus M; Lerebours E; Magro F; Mearin F; Mitchell D; Oldenburg B; Danese S
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1456-63. PubMed ID: 24100539
[TBL] [Abstract][Full Text] [Related]
3. A new concept for the differential diagnosis and therapy of anaemia in cancer patients.
Steinmetz HT; Tsamaloukas A; Schmitz S; Wiegand J; Rohrberg R; Eggert J; Breuer F; Tessen HW; Eustermann H; Thomas L
Support Care Cancer; 2010 Feb; 19(2):261-9. PubMed ID: 20148270
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia.
Steinmetz T; Tschechne B; Harlin O; Klement B; Franzem M; Wamhoff J; Tesch H; Rohrberg R; Marschner N
Ann Oncol; 2013 Feb; 24(2):475-482. PubMed ID: 23071262
[TBL] [Abstract][Full Text] [Related]
5. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study.
Lasocki S; Krauspe R; von Heymann C; Mezzacasa A; Chainey S; Spahn DR
Eur J Anaesthesiol; 2015 Mar; 32(3):160-7. PubMed ID: 25564780
[TBL] [Abstract][Full Text] [Related]
6. Chinese physician perception on the treatment of chemotherapy-induced anemia: online cross-section survey study.
Zhang J; Du Y; Meng Y; Liu X; Mu Y
Chin Clin Oncol; 2024 Feb; 13(1):5. PubMed ID: 38453656
[TBL] [Abstract][Full Text] [Related]
7. Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trial.
Chen L; Jiang H; Gao W; Tu Y; Zhou Y; Li X; Zhu Z; Jiang Q; Zhan H; Yu J; Fu C; Gao Y
BMJ Open; 2016 Oct; 6(10):e012231. PubMed ID: 27855097
[TBL] [Abstract][Full Text] [Related]
8. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron.
Henry DH; Dahl NV; Auerbach MA
Am J Hematol; 2012 Mar; 87(3):308-10. PubMed ID: 22262486
[TBL] [Abstract][Full Text] [Related]
10. Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort.
Yong K; Kairaitis L
Nephrology (Carlton); 2010 Apr; 15(3):288-93. PubMed ID: 20470296
[TBL] [Abstract][Full Text] [Related]
11. Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up.
Malyszko J; Drozdz M; Zolkiewicz A; Rutkowski B
Int Urol Nephrol; 2014 Jan; 46(1):71-82. PubMed ID: 23136027
[TBL] [Abstract][Full Text] [Related]
12. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced anemia at an urban academic medical center: iron studies and supplementation.
Shord SS; Cuellar S
J Am Pharm Assoc (2003); 2008; 48(4):487-93. PubMed ID: 18653424
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France.
Toledano A; Luporsi E; Morere JF; Scotté F; Laribi K; Barrière J; Huot-Marchand P; Duvillié L; Concas VH; Bugat R
Support Care Cancer; 2016 Jan; 24(1):67-75. PubMed ID: 25921449
[TBL] [Abstract][Full Text] [Related]
15. Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD Study.
Blumenstein I; Dignass A; Vollmer S; Klemm W; Weber-Mangal S; Stein J
J Crohns Colitis; 2014 Oct; 8(10):1308-14. PubMed ID: 24721157
[TBL] [Abstract][Full Text] [Related]
16. Erythropoiesis-stimulating agent dosing, haemoglobin and ferritin levels in UK haemodialysis patients 2005-13.
Birnie K; Caskey F; Ben-Shlomo Y; Sterne JA; Gilg J; Nitsch D; Tomson C
Nephrol Dial Transplant; 2017 Apr; 32(4):692-698. PubMed ID: 27190350
[TBL] [Abstract][Full Text] [Related]
17. European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment.
Repetto L; Moeremans K; Annemans L;
Cancer Treat Rev; 2006; 32 Suppl 2():S5-9. PubMed ID: 16725267
[TBL] [Abstract][Full Text] [Related]
18. Adherence to guidelines for use of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia: results of a retrospective study of an electronic medical-records database in the United States, 2002-2006.
Luo W; Nordstrom BL; Fraeman K; Nordyke R; Ranganathan G; Linz HE; Winterkorn A; Stokes M; Ross SD; Knopf K
Clin Ther; 2008 Dec; 30(12):2423-35. PubMed ID: 19167601
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia.
Pashos CL; Larholt K; Fraser KA; McKenzie RS; Senbetta M; Piech CT
Support Care Cancer; 2012 Jan; 20(1):159-65. PubMed ID: 21359879
[TBL] [Abstract][Full Text] [Related]
20. SEOM clinical guidelines for anaemia treatment in cancer patients (2020).
Escobar Álvarez Y; de Las Peñas Bataller R; Perez Altozano J; Ros Martínez S; Sabino Álvarez A; Blasco Cordellat A; Brozos Vázquez E; Corral Jaime J; García Escobar I; Beato Zambrano C
Clin Transl Oncol; 2021 May; 23(5):931-939. PubMed ID: 33768441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
